Cells infected by HIV defend themselves, research shows

The study identifies the mechanism on how the cell's innate immune system (known as the interferon response) responds to HIV infection and how the virus affects this interferon response. The viral protein Vpr triggers the interferon response in T cells (as also in dendritic cells, other cells of the immune system which are also infected by HIV). Vpu, another viral protein, suppresses the interferon response.
This discovery is the result of research by Dr. Jolien Vermeire and colleagues under supervision of Dr. Bruno Verhasselt at Ghent University and Ghent University Hospital
A better understanding of the innate defense against HIV could in the long term allow to complement the current treatment.
Because HIV infects and functionally impairs immune cells, untreated patients loose a functional immune system. As a consequence, germs and some cancers are given free rein (AIDS). Even if the virus is kept under control with medication, inflammation and degradation of established immunity is observed in some patients. This study provides a possible explanation why this happens and options to deal with this.
This research, published in the journal Cell Reports on October 4th 2016.



for more information visit our product website:  Retina A In Treating eye and skin problem
Location: United States

Comments

Post a Comment

Popular posts from this blog

Researchers closer than ever to a universal flu vaccine

Researchers at McMaster College and two American universities have taken one other step nearer to creating a way more efficient, "one-punch" common flu vaccine. Their newest findings, printed on-line within the journal  Proceedings of the Nationwide Academy of Science USA (PNAS) , construct upon their earlier discovery of a category of antibodies able to neutralizing essentially the most harmful kinds of Influenza viruses . These antibodies, in response to the researchers, basically "prepare" the immune system to acknowledge a portion of the virus that doesn't change from year-to-year and, in doing so, can pave the way in which towards a common vaccine that must be given simply as soon as and will shield towards all future strains of the flu, together with mutated strains. Seasonal flu vaccines work by producing antibodies that bind to the virus and stop it from infecting cells. Common flu vaccines do that ...
Read more

HIV cure hope thanks to collaboration

A partnership sparked by the National Institute for Health Research (NIHR) is behind this collaborative UK effort for the new treatment, which is a first-of-its-kind. Six years ago this month, a meeting took place between five leading UK research establishments which resulted in a shared commitment to find a cure for HIV. A partnership sparked by the National Office for Clinical Research Infrastructure (NOCRI), part of the NIHR, identified in that meeting that while there is research into treatment of HIV, as there is for many chronic conditions, there was no research into eradication of the disease. Each of the British research institutions present -- Oxford University, University of Cambridge, Imperial College London, King's College London and University College London -- agreed that they could provide a part of the jigsaw needed to find the cure, but could not achieve this in isolation. Managing Director of NOCRI Mark Samuels said: "This was a meeting of some of ...
Read more

Broadly neutralizing HIV antibodies pave the way for vaccine

We know from HIV research that around one percent of people infected with HIV form antibodies that combat different virus strains. These broadly neutralizing HIV antibodies (bnAbs) bind to structures on the surface of the virus which barely change and are identical in different viral strains. Dubbed "spikes," these sugar and protein complexes are the only surface structures that stem from the HIV virus itself and can be attacked by the immune system via antibodies. Due to their broad impact, these antibodies constitute a promising cornerstone for the development of an effective vaccine against HIV. Virus load, virus diversity and duration of infection encourage antibody formation A Switzerland-wide team of researchers headed by the University of Zurich and University Hospital Zurich conducted an extensive study on the factors responsible for the formation of broadly neutralizing antibodies against HIV. They examined around 4,500 people infected with HIV who are record...
Read more